Carcinogenesis, Vol. 23, No. 1, 67-72,
January 2002
© 2002 Oxford University Press
CANCER BIOLOGY |
The FANCG Fanconi anemia protein interacts with CYP2E1: possible role in protection against oxidative DNA damage
Hematology Branch, NHLBI, NIH, Building 10, Room 7C103, Bethesda, MD 20892, USA and
1 Pathology Section, NHLBI, NIH, Bethesda, MD 20892, USA
Fanconi anemia (FA) is a genetic disorder that leads to aplastic anemia and birth defects and predisposes to cancer. FA cells exhibit characteristic hypersensitivity to DNA cross-linking agents such as mitomycin C (MMC), and FANCG is one of six known FA gene products. By immunocytochemical analysis of transfected cells, we discovered that although FANCG localized to both the nucleus and cytoplasm, there was an increase in cells with predominantly cytoplasmic staining after treatment with MMC. Concurrently, while searching by two-hybrid analysis for proteins that associate with FANCG, we identified a novel interaction between FANCG and cytochrome P450 2E1 (CYP2E1). A member of the P450 superfamily, CYP2E1 is associated with the production of reactive oxygen intermediates and the bioactivation of carcinogens. High constitutive levels of CYP2E1 were found in a FA-G lymphoblast cell line, whereas complementation of the FA-G line with wild-type FANCG was associated with decreased CYP2E1. These findings suggested that the interaction of FANCG with CYP2E1 might alter redox metabolism and increase DNA oxidation. Using a fluorescent assay, we found a dose-dependent increase in the oxidized DNA base, 8-oxoguanine (8-oxoG), after treatment of mutant FA-G cells with H2O2 or MMC. Conversely, significantly lower levels of 8-oxoG were detected in FANCG-complemented FA-G cells. We conclude that the unknown function of FANCG involves at least transient interaction with cytoplasmic components, possibly including CYP2E1, and propose a role for FANCG in protection against oxidative DNA damage.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. Briot, G. Mace-Aime, F. Subra, and F. Rosselli Aberrant activation of stress-response pathways leads to TNF-{alpha} oversecretion in Fanconi anemia Blood, February 15, 2008; 111(4): 1913 - 1923. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Zhang, D. P. Sejas, Y. Qiu, D. A. Williams, and Q. Pang Inflammatory ROS promote and cooperate with the Fanconi anemia mutation for hematopoietic senescence J. Cell Sci., May 1, 2007; 120(9): 1572 - 1583. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. P. Sejas, R. Rani, Y. Qiu, X. Zhang, S. R. Fagerlie, H. Nakano, D. A. Williams, and Q. Pang Inflammatory Reactive Oxygen Species-Mediated Hemopoietic Suppression in Fancc-Deficient Mice J. Immunol., April 15, 2007; 178(8): 5277 - 5287. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Mukhopadhyay, K. S. Leung, M. J. Hicks, P. J. Hastings, H. Youssoufian, and S. E. Plon Defective mitochondrial peroxiredoxin-3 results in sensitivity to oxidative stress in Fanconi anemia J. Cell Biol., October 23, 2006; 175(2): 225 - 235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Zhang, J. Li, D. P. Sejas, and Q. Pang Hypoxia-reoxygenation induces premature senescence in FA bone marrow hematopoietic cells Blood, July 1, 2005; 106(1): 75 - 85. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Li, M. M. Le Beau, S. Ciccone, F.-C. Yang, B. Freie, S. Chen, J. Yuan, P. Hong, A. Orazi, L. S. Haneline, et al. Ex vivo culture of Fancc-/- stem/progenitor cells predisposes cells to undergo apoptosis, and surviving stem/progenitor cells display cytogenetic abnormalities and an increased risk of malignancy Blood, May 1, 2005; 105(9): 3465 - 3471. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Pagano, P. Degan, M. d'Ischia, F. J. Kelly, F. V. Pallardo, A. Zatterale, S.S. Anak, E. E. Akisik, G. Beneduce, R. Calzone, et al. Gender- and age-related distinctions for the in vivo prooxidant state in Fanconi anaemia patients Carcinogenesis, October 1, 2004; 25(10): 1899 - 1909. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Achanta and P. Huang Role of p53 in Sensing Oxidative DNA Damage in Response to Reactive Oxygen Species-Generating Agents Cancer Res., September 1, 2004; 64(17): 6233 - 6239. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-J. Park, S. L. M. Ciccone, B. D. Beck, B. Hwang, B. Freie, D. W. Clapp, and S.-H. Lee Oxidative Stress/Damage Induces Multimerization and Interaction of Fanconi Anemia Proteins J. Biol. Chem., July 16, 2004; 279(29): 30053 - 30059. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Lamerdin, N. A. Yamada, J. W. George, B. Souza, A. T. Christian, N. J. Jones, and L. H. Thompson Characterization of the hamster FancG/Xrcc9 gene and mutations in CHO UV40 and NM3 Mutagenesis, May 1, 2004; 19(3): 237 - 244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Brodeur, I. Goulet, C. S. Tremblay, C. Charbonneau, M.-C. Delisle, C. Godin, C. Huard, E. W. Khandjian, M. Buchwald, G. Levesque, et al. Regulation of the Fanconi Anemia Group C Protein through Proteolytic Modification J. Biol. Chem., February 6, 2004; 279(6): 4713 - 4720. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Yamamoto, M. Ishiai, N. Matsushita, H. Arakawa, J. E. Lamerdin, J.-M. Buerstedde, M. Tanimoto, M. Harada, L. H. Thompson, and M. Takata Fanconi Anemia FANCG Protein in Mitigating Radiation- and Enzyme-Induced DNA Double-Strand Breaks by Homologous Recombination in Vertebrate Cells Mol. Cell. Biol., August 1, 2003; 23(15): 5421 - 5430. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M D Tischkowitz and S V Hodgson Fanconi anaemia J. Med. Genet., January 1, 2003; 40(1): 1 - 10. [Abstract] [Full Text]
|
|
|
|
|
|
M. Bogliolo, O. Cabre, E. Callen, V. Castillo, A. Creus, R. Marcos, and J. Surralles The Fanconi anaemia genome stability and tumour suppressor network Mutagenesis, November 1, 2002; 17(6): 529 - 538. [Abstract] [Full Text] [PDF]
|
|